% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • tonytootsoon tonytootsoon Oct 28, 2013 1:30 PM Flag


    They are all shorting . Whatever no one has said it so here goes TIMBER. …….I am glad I only have a few hundred shares left as a long shot. High risk high reward so I stay through the trial submission.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • In a recent TheStreet article, Adam Feuerstein says there's only flimsy evidence that ganetespib in the ongoing phase III study is statistically significant (compared to conventional mixes alone).

      He was right in his alert calls on CLSN, GXTI, ZIOP, and CPRX. all have since gone bust. I'm beginning to believe this guy.

      • 2 Replies to silverlinj
      • I accumulated CPRX from 80 cents and it went up above 3 too fast. Even I knew it was hyped too much and cashed out most of my shares. Then he started bashing CPRX when his clients apparently finished building up large short position. Thanks for his bashing. I am now watching CPRX too and will choose the timing to increase my positions on CPRX under 2.

        If you think AF is doing pure journalism without money motives, you are fooling yourself.

      • CLSN data was 100x weaker than this. In fact they had a Ph2 with 10 patients total. They didn't do the ground work this company has done to make sure things work.

        You should also keep in mind the high flyers he has gotten very very wrong. My personal experience was Kerx, but there is also ACAD and others.

0.3606-0.0194(-5.11%)May 26 4:00 PMEDT